Integrating ATCC Authenticated Cell Lines into your CRISPR Gene Editing Workflows

CRISPR genome-editing platforms are being increasingly employed to accelerate drug discovery and cell and gene therapy applications. However, the cells that are critical feedstocks for these applications are complex, and not all cells are equal. To empower scientists to cogently incorporate genome editing into their workflows, ATCC has partnered with the genome editing company EditCo. In this collaboration, ATCC will offer its extensive collection of mammalian and mouse cell lines for genome engineering. Here, ATCC experts will discuss points to consider when choosing cells for editing, including cell procurement, banking, authentication, and characterization at ATCC. Next, an EditCo scientist will showcase the applications of the many genome editing workflows that they provide. Finally, the webinar will close with a lively Q and A session where industry leaders will discuss the audience’s questions.